Lisa Bodei

12PUBLICATIONS
57CO-AUTHORS
Molecular targetsRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 15, 2026
Recent Developments in the Diagnosis and Treatment of Disseminated and Rare Melanoma with Radiotheranostics.

|Feb 02, 2026
Next-generation anti-DLL3 radiopharmaceuticals targeting high-grade neuroendocrine lung and prostate cancers.

Salomon Tendler, Roberto De Gregorio, Paul Balderes

|Nov 24, 2025
Differential Clearance of [177Lu]Lu-PSMA-617 from Metastatic Prostate Cancer Lesions and Normal Tissues creates a Window for Safe Application of DNA Repair Inhibitors.

James Russell, Milan Grkovski, Joseph A O'Donoghue

|Nov 20, 2025
Delta-Like Ligand 3 Expression and Functional Imaging in Gastroenteropancreatic Neuroendocrine Neoplasms.

Rohit Thummalapalli, Salomon Tendler, Joanne F Chou

|May 02, 2025
Systemic Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer: ASCO Guideline Update.

Rohan Garje, Irbaz Bin Riaz, Syed Arsalan Ahmed Naqvi

|May 16, 2024
Clinical management of typical and atypical carcinoids/neuroendocrine tumors in ENETS centres of excellence (CoE): Survey from the ENETS lung NET task force.

Anna Koumarianou, Pier Luigi Filosso, Lisa Bodei

Pageof 2

Frequent Collaborators

5 joint publications

Jason S Lewis

3 joint publications

Charles M Rudin

2 joint publications

George Sgouros

2 joint publications

Jessie R Nedrow